Health TrialsbyHealthPanel

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

ConditionAlpha-1 Antitrypsin Deficiency
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Florida

About this trial

The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Individuals of any age at risk for alpha-1 antitrypsin deficiency on the basis of symptoms or family genetic risk.

Disqualifiers

Any person who has already had genotype and AAT level testing completed and has a qualified result.

Trial population

Individuals choosing to test at home for alpha-1 antitrypsin deficiency.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Alpha-1 Antitrypsin Genotype

    Procedure/Surgery

    Home fingerstick testing for alpha-1 antitrypsin genotype

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Structured questionnaire responses on the risks and benefits of testing.

Rotating questionnaires assess the clinical course and co-morbidities associated with different genotypes of alpha-1 antitrypsin deficiency.

Time frame
Before and after alpha-1 antitrypsin testing

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Florida

Lead sponsor

Source ClinicalTrials.gov
Apply now